Pharmacokinetics of olanzapine long-acting injection: the clinical perspective

Olanzapine long-acting injection (OLAI) is a sustained-release depot antipsychotic for the treatment of schizophrenia in adults. Our objective was to explain the pharmacokinetics of OLAI to provide clinical insight. Simulation models and data from clinical trials are presented. Olanzapine concentrat...

Descripción completa

Detalles Bibliográficos
Autores principales: Heres, Stephan, Kraemer, Susanne, Bergstrom, Richard F., Detke, Holland C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams And Wilkins 2014
Materias:
Review Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186727/
https://www.ncbi.nlm.nih.gov/pubmed/24815672
http://dx.doi.org/10.1097/YIC.0000000000000040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186727/
https://www.ncbi.nlm.nih.gov/pubmed/24815672
http://dx.doi.org/10.1097/YIC.0000000000000040

Ejemplares similares